Get the Stockscreener App
170.72
0.45%
0.76
After Hours:
170.72
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $170.72, with a volume of 564.27K.
It is up +0.45% in the last 24 hours and up +0.28% over the past month.
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$169.96
Open:
$169.25
24h Volume:
564.27K
Relative Volume:
1.23
Market Cap:
$9.08B
Revenue:
$2.04B
Net Income/Loss:
$78.60M
P/E Ratio:
117.74
EPS:
1.45
Net Cash Flow:
$149.60M
1W Performance:
-5.84%
1M Performance:
+0.28%
6M Performance:
+42.34%
1Y Performance:
+29.13%
1-Day Range:
$166.60
$171.96
1-Week Range:
$166.60
$184.51
52-Week Range:
$101.61
$184.51
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
170.72 | 9.08B | 2.04B | 78.60M | 149.60M | 1.45 |
|
ABT
Abbott Laboratories
|
134.95 | 234.06B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.39 | 154.06B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
387.92 | 148.02B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.17 | 115.71B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.76 | 42.91B | 5.72B | 4.17B | 490.10M | 6.97 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Masimo Corporation Q4 2024 Earnings Preview - MSN
Rhumbline Advisers Has $20.56 Million Holdings in Masimo Co. (NASDAQ:MASI) - MarketBeat
Masimo Corp announces bylaw amendments and shareholder rights - Investing.com
Masimo Corp announces bylaw amendments and shareholder rights By Investing.com - Investing.com South Africa
Masimo Corporation filed SEC Form 8-K: Leadership Update, Shareholder Director Nominations, Other Events, Financial Statements and Exhibits - Quantisnow
Price Over Earnings Overview: Masimo - Benzinga
Sumitomo Mitsui Trust Group Inc. Has $61.77 Million Holdings in Masimo Co. (NASDAQ:MASI) - MarketBeat
(MASI)Analyzing Masimo's Short Interest - Benzinga
Lecap Asset Management Ltd. Acquires New Holdings in Masimo Co. (NASDAQ:MASI) - MarketBeat
Retirement Systems of Alabama Sells 60,225 Shares of Masimo Co. (NASDAQ:MASI) - MarketBeat
Can Mixed Fundamentals Have A Negative Impact on Masimo Corporation (NASDAQ:MASI) Current Share Price Momentum? - Yahoo Canada Finance
Wilmington Savings Fund Society FSB Cuts Stock Position in Masimo Co. (NASDAQ:MASI) - MarketBeat
Trust Point Inc. Buys New Shares in Masimo Co. (NASDAQ:MASI) - MarketBeat
Masimo Corp announces executive departure By Investing.com - Investing.com Nigeria
Masimo Corp announces executive departure - MSN
Masimo Fires General Counsel McClenahan - Orange County Business Journal
Masimo Corp. (MASI) terminates EVP/General Counsel - StreetInsider.com
Here's How Much $1000 Invested In Masimo 15 Years Ago Would Be Worth Today - Benzinga
Apple Seeks Bench Trial Win In Masimo's Trade Secret Suit - Law360
Masimo Corp announces board member resignation By Investing.com - Investing.com UK
Masimo Corp announces board member resignation - MSN
Masimo Board Member Robert Chapek Announces Resignation - MSN
Masimo stock soars to 52-week high, hits $181.13 By Investing.com - Investing.com Nigeria
Masimo stock soars to 52-week high, hits $181.13 - Investing.com
Can Masimo (MASI) Keep the Earnings Surprise Streak Alive? - Yahoo Finance
Apple defends against Masimo's trade secret claims after sealed trial - Daily Journal
Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO - Orange County Business Journal
Joe Kiani Unveils New Diabetes Venture - Orange County Business Journal
Crossmark Global Holdings Inc. Sells 88 Shares of Masimo Co. (NASDAQ:MASI) - Defense World
UMB Bank n.a. Purchases 123 Shares of Masimo Co. (NASDAQ:MASI) - Defense World
Midday Stock Roundup: Virgin Galactic down 2.3% and 87% YoY - Orange County Business Journal
Masimo names med-tech vet Katie Szyman CEO - BioWorld Online
Masimo taps Becton Dickinson executive Katie Szyman as CEO - Reuters
Here's Why Masimo (MASI) is a Great Momentum Stock to Buy - Yahoo Finance
Needham & Company LLC Reaffirms Hold Rating for Masimo (NASDAQ:MASI) - MarketBeat
Masimo Appoints Catherine ‘Katie’ Syzman as CEO & Board Member - Strata-gee.com
Deep Dive Into Masimo Stock: Analyst Perspectives (7 Ratings) - Benzinga
Masimo names Becton Dickinson's Katie Szyman CEO -January 21, 2025 at 04:57 pm EST - Marketscreener.com
Masimo Appoints Katie Szyman as Permanent CEO - Orange County Business Journal
Masimo Corp. (MASI) names Katie Szyman as new CEO - StreetInsider.com
Masimo Names BD Healthcare Veteran Katie Szyman as New CEO, Reshapes Leadership Team - StockTitan
Masimo Stock Gains Following Solid Preliminary Q4 Revenues - Yahoo Finance
Needham maintains Hold on Masimo stock following revenue preannouncement - MSN
MASI (Masimo) 3-Year FCF Growth Rate : -62.60% (As of Sep. 2024) - GuruFocus.com
Masimo (NASDAQ:MASI) Earns “Hold” Rating from Needham & Company LLC - Defense World
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):